Besides surgical resection as the treatment option of choice, clinicians should be aware of new treatment strategies using inhibitors of the mTOR signaling pathway, which is commonly activated in PEComas. Here, MTOR is linked to neoplasm with perivascular epithelioid cell differentiation.